The U.S. Food and Drug Administration (FDA) has granted accelerated approval for the immunotherapy afamitresgene autoleuecel (Tecelra®, also known as afami-cel) for the treatment of adults with a rare soft tissue cancer called synovial sarcoma.
The secret to human brain’s learning efficiency revealed
Researchers from the MRC Brain Network Dynamics Unit and Oxford University’s Department of Computer Science have set out a new principle to explain how the